IMA Advisory Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.28K Hold
100
﹤0.01% 369
2025
Q4
$6.64K Hold
100
﹤0.01% 372
2025
Q3
$6.73K Hold
100
﹤0.01% 326
2025
Q2
$8.73K Hold
100
﹤0.01% 313
2025
Q1
$6.83K Buy
+100
New +$8.16K ﹤0.01% 315
2024
Q4
Sell
-100
Closed -$6.7K 207
2024
Q3
$6.7K Buy
+100
New +$8.21K ﹤0.01% 248
2022
Q4
Sell
-4
Closed 376
2022
Q3
$0 Buy
+4
New +$339 ﹤0.01% 355

Other funds holding DXCM

IMA Advisory Services's DXCM Position: Q1 2026 in Review

IMA Advisory Services held its DexCom (DXCM) position steady in Q1 2026 at 100 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

IMA Advisory Services first reported a position in DXCM in Q3 2022 and has held it in 7 quarters since. The position peaked at $8.73K in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • IMA Advisory Services held 100 shares of DexCom worth $6.28K as of Q1 2026.
  • IMA Advisory Services left its DexCom share count unchanged in Q1 2026.
  • DexCom made up ﹤0.01% of IMA Advisory Services's portfolio in Q1 2026, its #369 holding.
  • IMA Advisory Services first reported a position in DexCom in Q3 2022 and has held it in 7 quarters since.
  • IMA Advisory Services's DexCom position peaked at $8.73K in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.